Amanote Research

Amanote Research

    RegisterSign In

Quantitative Proteomics to Study a Small Molecule Targeting the Loss of Von Hippel-Lindau in Renal Cell Carcinomas

International Journal of Cancer - United States
doi 10.1002/ijc.30774
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

May 25, 2017

Authors
Nadia BouhamdaniAndrew JoyDavid BarnettKevin CormierDaniel LégerIan C. ChuteSimon LamarreRodney OuelletteSandra Turcotte
Publisher

Wiley


Related search

Targeted Therapy for the Loss of Von Hippel-Lindau in Renal Cell Carcinoma: A Novel Molecule That Induces Autophagic Cell Death

Autophagy
Cell BiologyMolecular Biology
2008English

-Catenin Links Von Hippel-Lindau to Aurora Kinase a and Loss of Primary Cilia in Renal Cell Carcinoma

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma

Journal of Kidney Cancer and VHL
2015English

Von Hippel-Lindau

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Von Hippel–Lindau Disease

Handbook of Clinical Neurology
2015English

Von Hippel-Lindau Disease

English

A Review of Von Hippel-Lindau Syndrome

Journal of Kidney Cancer and VHL
2017English

Von Hippel-Lindau Disease: An Update

Current Genetic Medicine Reports
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy